Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deli Song

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Iscience|June 29, 2026
Clinical dose of enoxaparin enhances oncolytic virus M1 infection and antitumor efficacy in human bladder cancerXiaoting Xiao, Xudong Jia, Runling Shen, et al.
Human Gene Therapy|January 28, 2021
Real-Time Visualization and Quantification of Oncolytic M1 Virus <i>In Vitro</i> and <i>In Vivo</i>Wenbo Zhu, Jiankai Liang, Jingyi Tan, et al.
Nature Communications|June 9, 2023
Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profileLi Guo, Cheng Hu, Yang Liu, et al.
Oncogene|June 22, 2021
Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBCJiayu Zhang, Ying Liu, Jingyi Tan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 6, 2025
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1Linyi Hu, Guigen Zhang, Yuan Lin, et al.
Cell|June 10, 2026
RNA structure programs endogenous ADAR for precise and efficient editingDeli Song, Gexing Liu, Wei Zhang, et al.
Signal Transduction and Targeted Therapy|April 8, 2022
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumorsDeli Song, Xudong Jia, Xincheng Liu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Iscience|June 29, 2026
Clinical dose of enoxaparin enhances oncolytic virus M1 infection and antitumor efficacy in human bladder cancerXiaoting Xiao, Xudong Jia, Runling Shen, et al.
Human Gene Therapy|January 28, 2021
Real-Time Visualization and Quantification of Oncolytic M1 Virus <i>In Vitro</i> and <i>In Vivo</i>Wenbo Zhu, Jiankai Liang, Jingyi Tan, et al.
Nature Communications|June 9, 2023
Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profileLi Guo, Cheng Hu, Yang Liu, et al.
Oncogene|June 22, 2021
Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBCJiayu Zhang, Ying Liu, Jingyi Tan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 6, 2025
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1Linyi Hu, Guigen Zhang, Yuan Lin, et al.
Cell|June 10, 2026
RNA structure programs endogenous ADAR for precise and efficient editingDeli Song, Gexing Liu, Wei Zhang, et al.
Signal Transduction and Targeted Therapy|April 8, 2022
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumorsDeli Song, Xudong Jia, Xincheng Liu, et al.
Pageof 3